These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 10906441)
1. In vitro cytotoxicity tests on cultured human skin fibroblasts to predict skin irritation potential of surfactants. Lee JK; Kim DB; Kim JI; Kim PY Toxicol In Vitro; 2000 Aug; 14(4):345-9. PubMed ID: 10906441 [TBL] [Abstract][Full Text] [Related]
2. MTT-assay and neutral red release (NRR)-assay: relative role in the prediction of the irritancy potential of surfactants. Korting HC; Schindler S; Hartinger A; Kerscher M; Angerpointner T; Maibach HI Life Sci; 1994; 55(7):533-40. PubMed ID: 8041231 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of eye and skin irritation of arginine-derivative surfactants using different in vitro endpoints as alternatives to the in vivo assays. Martinez V; Corsini E; Mitjans M; Pinazo A; Vinardell MP Toxicol Lett; 2006 Jul; 164(3):259-67. PubMed ID: 16472949 [TBL] [Abstract][Full Text] [Related]
4. An approach for development of alternative test methods based on mechanisms of skin irritation. Osborne R; Perkins MA Food Chem Toxicol; 1994 Feb; 32(2):133-42. PubMed ID: 8132172 [TBL] [Abstract][Full Text] [Related]
5. Assessment of primary eye and skin irritants by in vitro cytotoxicity and phototoxicity models: an in vitro approach of new arginine-based surfactant-induced irritation. Benavides T; Mitjans M; Martínez V; Clapés P; Infante MR; Clothier RH; Vinardell MP Toxicology; 2004 May; 197(3):229-37. PubMed ID: 15033545 [TBL] [Abstract][Full Text] [Related]
6. The benefits of the 3T3 NRU test in the safety assessment of cosmetics: long-term experience from pre-marketing testing in the Czech Republic. Jírová D; Kejlová K; Brabec M; Bendová H; Kolárová H Toxicol In Vitro; 2003; 17(5-6):791-6. PubMed ID: 14599479 [TBL] [Abstract][Full Text] [Related]
7. Measurement of cytotoxicity and irritancy potential of sugar-based surfactants on skin-related 3D models. Lu B; Miao Y; Vigneron P; Chagnault V; Grand E; Wadouachi A; Postel D; Pezron I; Egles C; Vayssade M Toxicol In Vitro; 2017 Apr; 40():305-312. PubMed ID: 28163247 [TBL] [Abstract][Full Text] [Related]
8. Assessment of the potential skin irritation of lysine-derivative anionic surfactants using mouse fibroblasts and human keratinocytes as an alternative to animal testing. Sanchez L; Mitjans M; Infante MR; Vinardell MP Pharm Res; 2004 Sep; 21(9):1637-41. PubMed ID: 15497690 [TBL] [Abstract][Full Text] [Related]
9. Discrimination of the irritancy potential of surfactants in vitro by two cytotoxicity assays using normal human keratinocytes, HaCaT cells and 3T3 mouse fibroblasts: correlation with in vivo data from a soap chamber assay. Korting HC; Herzinger T; Hartinger A; Kerscher M; Angerpointner T; Maibach HI J Dermatol Sci; 1994 Apr; 7(2):119-29. PubMed ID: 8060913 [TBL] [Abstract][Full Text] [Related]
10. Comparative studies on the ocular and dermal irritation potential of surfactants. Mehling A; Kleber M; Hensen H Food Chem Toxicol; 2007 May; 45(5):747-58. PubMed ID: 17169473 [TBL] [Abstract][Full Text] [Related]
11. Establishment and evaluation of immortalized human epidermal keratinocytes for an alternative skin irritation test. Kim CW; Kim CD; Choi KC J Pharmacol Toxicol Methods; 2017; 88(Pt 2):130-139. PubMed ID: 28827132 [TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of primary skin irritants in vitro in a cytotoxicity model: comparison with in vivo human irritation tests. Wilhelm KP; Böttjer B; Siegers CP Br J Dermatol; 2001 Nov; 145(5):709-15. PubMed ID: 11736893 [TBL] [Abstract][Full Text] [Related]
13. Arachidonic acid release: an in vitro alternative for dermal irritancy testing. DeLeo VA; Carver MP; Hong J; Fung K; Kong B; DeSalva S Food Chem Toxicol; 1996 Feb; 34(2):167-76. PubMed ID: 8606033 [TBL] [Abstract][Full Text] [Related]
14. In-house assessment of a modified in vitro cytotoxicity assay for higher throughput estimation of acute toxicity. King AV; Jones PA Toxicol In Vitro; 2003; 17(5-6):717-22. PubMed ID: 14599468 [TBL] [Abstract][Full Text] [Related]
15. Arachidonic acid release and prostaglandin E2 synthesis as irritant index of surfactants in 3T6 fibroblast cultures. Moreno JJ Toxicology; 2000 Mar; 143(3):275-82. PubMed ID: 10755713 [TBL] [Abstract][Full Text] [Related]
16. Assessment of human epidermal model LabCyte EPI-MODEL for in vitro skin irritation testing according to European Centre for the Validation of Alternative Methods (ECVAM)-validated protocol. Katoh M; Hamajima F; Ogasawara T; Hata K J Toxicol Sci; 2009 Jun; 34(3):327-34. PubMed ID: 19483386 [TBL] [Abstract][Full Text] [Related]
17. Skin2--an in vitro human skin model: the correlation between in vivo and in vitro testing of surfactants. Demetrulias J; Donnelly T; Morhenn V; Jessee B; Hainsworth S; Casterton P; Bernhofer L; Martin K; Decker D Exp Dermatol; 1998 Feb; 7(1):18-26. PubMed ID: 9517918 [TBL] [Abstract][Full Text] [Related]
18. In vitro skin irritation testing on reconstituted human epidermis: reproducibility for 50 chemicals tested with two protocols. Tornier C; Rosdy M; Maibach HI Toxicol In Vitro; 2006 Jun; 20(4):401-16. PubMed ID: 16229985 [TBL] [Abstract][Full Text] [Related]
19. An in vitro model for detecting skin irritants: methyl green-pyronine staining of human skin explant cultures. Jacobs JJ; Lehé C; Cammans KD; Das PK; Elliott GR Toxicol In Vitro; 2002 Oct; 16(5):581-8. PubMed ID: 12206825 [TBL] [Abstract][Full Text] [Related]
20. Comparative assessment of 24-hr primary skin irritation test and human patch test data with in vitro skin irritation tests according to OECD Test Guideline 439 (for quasi-drugs in Japan). Sugiyama M; Akita M; Alépée N; Fujishiro M; Hagino S; Handa Y; Ikeda H; Imai N; Jitsukawa S; Katoh M; Kurihara K; Kyotani D; Nomura S; Okamoto Y; Okumura H; Omori T; Sugibayashi K; Todo H; Toyoda A; Ohno Y J Toxicol Sci; 2018; 43(12):751-768. PubMed ID: 30518713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]